Drugs / Human Umbilical Cord Blood Mononuclear Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04099381 | Aug 2019 → Dec 2023 | autism | State-Financed Health Facility "Samara Regional Medical Center Dinasty" | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human Umbilical Cord Blood Mononuclear Cells | “The Human Umbilical Cord Blood Mononuclear Cells (hUCB-MNCs) have been shown to have the ability to modulate the immune response and enhance angiogenesis” NCT04099381 ↗ |
| Known as | hUCB-MNCs | “The Human Umbilical Cord Blood Mononuclear Cells (hUCB-MNCs) have been shown to have the ability to modulate the immune response and enhance angiogenesis” NCT04099381 ↗ |